UA54079A - Способ профилактики субклинического гипотиреоза у беременных юного возраста - Google Patents
Способ профилактики субклинического гипотиреоза у беременных юного возраста Download PDFInfo
- Publication number
- UA54079A UA54079A UA2002043661A UA200243661A UA54079A UA 54079 A UA54079 A UA 54079A UA 2002043661 A UA2002043661 A UA 2002043661A UA 200243661 A UA200243661 A UA 200243661A UA 54079 A UA54079 A UA 54079A
- Authority
- UA
- Ukraine
- Prior art keywords
- dose
- days
- iodine
- daily
- biologically active
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 208000003532 hypothyroidism Diseases 0.000 title claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 22
- 210000001685 thyroid gland Anatomy 0.000 claims abstract description 22
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000011630 iodine Substances 0.000 claims abstract description 19
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 18
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 17
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 17
- 229940082787 spirulina Drugs 0.000 claims abstract description 17
- 241000736355 Euthyroides Species 0.000 claims abstract description 9
- 230000000069 prophylactic effect Effects 0.000 claims abstract description 6
- 230000002265 prevention Effects 0.000 claims description 21
- 230000003449 preventive effect Effects 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 4
- 238000012876 topography Methods 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 abstract description 8
- 206010018498 Goitre Diseases 0.000 description 12
- 238000011282 treatment Methods 0.000 description 9
- 102000011923 Thyrotropin Human genes 0.000 description 8
- 108010061174 Thyrotropin Proteins 0.000 description 8
- 230000035935 pregnancy Effects 0.000 description 8
- 201000003872 goiter Diseases 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000003054 hormonal effect Effects 0.000 description 6
- 206010020718 hyperplasia Diseases 0.000 description 6
- 239000005495 thyroid hormone Substances 0.000 description 6
- 229940036555 thyroid hormone Drugs 0.000 description 6
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 201000008492 nontoxic goiter Diseases 0.000 description 5
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000010606 normalization Methods 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000005856 abnormality Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002989 hypothyroidism Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000008494 nodular goiter Diseases 0.000 description 2
- 230000008506 pathogenesis Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 201000011461 pre-eclampsia Diseases 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000002594 sorbent Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- XUIIKFGFIJCVMT-GFCCVEGCSA-N D-thyroxine Chemical compound IC1=CC(C[C@@H](N)C(O)=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-GFCCVEGCSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000030836 Hashimoto thyroiditis Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029783 Normochromic normocytic anaemia Diseases 0.000 description 1
- 206010036697 Primary hypothyroidism Diseases 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000024770 Thyroid neoplasm Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 230000009760 functional impairment Effects 0.000 description 1
- 230000006589 gland dysfunction Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 230000002390 hyperplastic effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000011649 selenium Nutrition 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 201000002510 thyroid cancer Diseases 0.000 description 1
- 229940034208 thyroxine Drugs 0.000 description 1
- XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 229940035722 triiodothyronine Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Способ профилактики субклинического гипотиреоза у беременных юного возраста предусматривает применение йодсодержащих биологически активных средств. Профилактический курс начинают при значении интегрального тиреоидного индекса от 3,69 до 7,03 с перорального приема энтеросорбента "Энсорал" в дозе 7,5 г ежедневно на протяжении 10 дней. После десятидневного перерыва принимают биологически активный препарат "Спирулина крымская йодсодержащая" ежедневно в дозе 2 г. После второго десятидневного перерыва – в дозе 1 г на протяжении 10-12 дней. Назначенную дозу биологически активного препарата "Спирулина крымская йодсодержащая" принимают в два приема. В случае необходимости назначают повторные профилактические курсы с перерывами между ними в 30 дней до достижения эутиреоидного состояния.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002043661A UA54079A (ru) | 2002-04-30 | 2002-04-30 | Способ профилактики субклинического гипотиреоза у беременных юного возраста |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UA2002043661A UA54079A (ru) | 2002-04-30 | 2002-04-30 | Способ профилактики субклинического гипотиреоза у беременных юного возраста |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA54079A true UA54079A (ru) | 2003-02-17 |
Family
ID=74305879
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2002043661A UA54079A (ru) | 2002-04-30 | 2002-04-30 | Способ профилактики субклинического гипотиреоза у беременных юного возраста |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA54079A (ru) |
-
2002
- 2002-04-30 UA UA2002043661A patent/UA54079A/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stolman et al. | Pyoderma gangrenosum and rheumatoid arthritis | |
| Hill et al. | Infants exposed in utero to antiepileptic drugs: a prospective study | |
| WO2010140926A1 (ru) | Стимулятор половой, сексуальной и репродуктивной функции | |
| LABBY et al. | Intravenous therapy of cirrhosis of the liver | |
| RU2455012C1 (ru) | Способ энтеральной детоксикации при лечении иммунных нарушений | |
| Markham et al. | Peritoneal dialysis in quinine sulfate intoxication | |
| UA54079A (ru) | Способ профилактики субклинического гипотиреоза у беременных юного возраста | |
| SHUMAN | Relapsing panniculitis (Weber-Christian disease): review of literature and report of a case including treatment with cortisone | |
| Watt et al. | Areas of uncertainty in the management of human trichinellosis: a clinical perspective | |
| Ch'ien et al. | Sydenham's chorea and seizures: clinical and electroencephalographic studies | |
| Hyser et al. | Myoclonus induced by metoclopramide therapy | |
| Akleyev | Clinical manifestations of chronic radiation syndrome | |
| RU2163813C1 (ru) | Биогенный препарат, пищевая добавка на его основе и способ их получения | |
| Nash et al. | LXXXIV Functions of the Parotid Gland | |
| Krull et al. | Venous-compression test in hyperparathyroidism | |
| RU2187311C2 (ru) | Способ лечения геморрагического васкулита у детей | |
| Domingo et al. | Parenteral citric acid for aluminium intoxication | |
| Schneider et al. | Hypervitaminosis D | |
| MORLOCK et al. | The coexistence of tophaceous gout and nontropical sprue. Report of a case | |
| Satyawardhana | A Classic Dermatomyositis: A Case Report of Rare Idiopathic Inflammatory Myopathy | |
| SUTRO et al. | Basis and treatment of calcification of tendinocapsular tissues, especially the supraspinatus tendon | |
| Khachadurian | Amino-aciduria secondary to a functioning parathyroid carcinoma | |
| RU2183464C2 (ru) | Способ комплексного лечения острого пиелонефрита родильниц | |
| LEVELS | POSSIBLE LATE MUSTARD GAS KERATITIS | |
| Van den Hoogen et al. | Rebound of anti-topoisomerase I antibody titres after plasma exchange |